Single-use bioreactors available today are robust and offers high
performance which is necessary for the commercial manufacturing of
biopharmaceutical products. Improvements in the bioreactor designs,
film technology, sensor systems and stirring mechanisms are resulting
in the increasing adoption of the single-use bioreactors.
Manufacturers are also closely working with their customers to comply
with the changing needs such as for next-gen gene and cell therapies,
and for continuous bioprocessing. New generation single-use
bioreactors are being designed while keeping in mind the processes
and final drug product perspectives by the end users.
According to the latest report compiled by Transparency Market
Research (TMR), the global single-use bioreactors market is expected
to witness robust growth. It is also estimated to increase to 13.5%
CAGR throughout the forecast period 2017-2026. The market is also
projected to reach US$ 1,547.3 million revenue by 2026 end.
The global single-use bioreactors market is segmented on the basis of
product type, cells type, end user and molecule type. Based on the
product type, the segmentation consists of media bags, single use
bioreactor systems and filtration assemblies. Among these, single use
bioreactor systems are anticipated to witness significant growth
throughout the forecast period. Based on the cells type, the market
is categorized into bacterial cells, mammalian cells, yeast cells,
and others. Between 2017 and 2026, mammalian cells are expected to
witness the highest growth.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2108
By end user, biopharmaceutical companies are anticipated to emerge as
the largest users of the single-use bioreactors during 2017-2026. In
the terms of molecule type, the segment includes gene-modified cells,
stem cells, vaccines, monoclonal antibodies (MABS) and others. Among
aforementioned molecule types, monoclonal antibodies (MABS) is likely
to witness strong growth in the global single-use bioreactors market
between 2017 and 2026.
Recent developments in single-use bioreactors by manufacturers are
focused on improving mixing, reducing complexity, and avoid leakage
and integrity issues. Improvements in the cell-culture processes are
also leading to the rise in adoption of single-use bioreactors.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2108
Europe is anticipated to be the most dominating region in the global
single-use bioreactors market during 2017-2026. Owing to the presence
of some of the world’s leading pharmaceutical companies in Europe,
the region is likely to witness growth. The region is expected to
account for the largest share, due to the patient cliff of many
biologics drugs in the region and the strong support by the
government to the biopharmaceutical companies in order to establish
new therapies in biologics. Also, the increasing use of single-use
bioreactors in cell culture-based manufacturing is driving the demand
in the region. Single-use bioreactors are also becoming
technologically advanced and are also being provided at competitive
cost.
Meanwhile, North America and APEJ are also likely to witness growth
in the single-use bioreactors market. Increasing investment by
biopharmaceutical companies to establish their manufacturing
facilities is driving the growth in APEJ. Increasing focus on
research activities and well-established healthcare industry is
resulting in the growth of the market in North America.
Purchase this Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=2108<ype=S
Some of the key market players in the report are Sartorius Merck
Millipore, Stedim Biotech, GE Healthcare, Thermo Fisher Scientific,
Danaher, Parker Hannifin, Eppendorf, Applikon Biotechnology, Cesco
Bioengineering, Celltainer Biotech, Cellexus, PBS Biotech, Distek,
Pierre Guerin, and Solida Biotech.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment